Gene · 64115
Papers2,513
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,513
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bone marrow tumor microenvironment profiling predicts distinct immunosuppressive phenotypes and immunotherapy potential in AML patients. | Biomed Pharmacother | 2025 | 40555045 | PubTator, text mining | PubMed |
| Computational Mapping of Conformational Dynamics and Interaction Hotspots of Human VISTA with pH-Selective Antibodies. | Biochemistry | 2025 | 40512745 | PubTator, text mining | PubMed |
| [IGSF11: A Novel Target for Cancer Immunotherapy]. | Zhongguo Fei Ai Za Zhi | 2025 | 40506491 | PubTator, text mining | PubMed |
| The tumor microenvironment of non-small cell lung cancer impairs immune cell function in people with HIV. | J Clin Invest | 2025 | 40459946 | PubTator, text mining | PubMed |
| The bispecific antibody targeting VISTA and PD-L1 shows enhanced tumor inhibitory activity in pancreatic, endometrial and breast cancers compared to mono- and combination immune checkpoint blockade. | Front Immunol | 2025 | 40416959 | PubTator, text mining | PubMed |
| Expression of VISTA on T cells in patients with cancer colon. | J Egypt Natl Canc Inst | 2025 | 40408043 | PubTator, text mining | PubMed |
| Revealing the mechanisms and therapeutic potential of immune checkpoint proteins across diverse protein families. | Front Immunol | 2025 | 40356928 | PubTator, text mining | PubMed |
| VISTA as a context-dependent immune checkpoint: Implications for tumor immunity and autoimmune pathogenesis. | Biochim Biophys Acta Rev Cancer | 2025 | 40350098 | PubTator, text mining | PubMed |
| Twist1 Regulates the Immune Checkpoint VISTA and Promotes the Proliferation, Migration and Progression of Pancreatic Cancer Cells. | J Cell Mol Med | 2025 | 40344465 | PubTator, text mining | PubMed |
| Macrophages suppress CD8 + T cell cytotoxic function in triple negative breast cancer via VISTA. | Br J Cancer | 2025 | 40316725 | PubTator, text mining | PubMed |
| The effect of immunomodulatory celecoxsib on the gene expression of inhibitory receptors in dendritic cells generated from monocyte cells. | BMC Res Notes | 2025 | 40223111 | PubTator, text mining | PubMed |
| Emerging new immune checkpoint inhibitors in solid tumor immunotherapy. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 40214728 | PubTator, text mining | PubMed |
| Pan-cancer analysis of co-inhibitory molecules revealing their potential prognostic and clinical values in immunotherapy. | Front Immunol | 2025 | 40196117 | PubTator, text mining | PubMed |
| Decreased expression of the immune checkpoint regulator VISTA on neutrophils correlates with disease activity in autoimmune uveitis. | FEBS J | 2025 | 40145147 | PubTator, text mining | PubMed |
| Galectin-3 regulates erythropoiesis and enhances the immunoregulatory properties of CD71+ erythroid cells across developmental stages. | J Immunol | 2025 | 40119673 | PubTator, text mining | PubMed |
| Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancer. | Cell Commun Signal | 2025 | 40108668 | PubTator, text mining | PubMed |
| Discovery of bifunctional small molecules targeting PD-L1/VISTA with favorable pharmacokinetics for cancer immunotherapy. | Bioorg Chem | 2025 | 40049048 | PubTator, text mining | PubMed |
| Discovery, Synthesis, and Activity Evaluation of Novel Small-Molecule Inhibitors Targeting VISTA for Cancer Immunotherapy. | J Med Chem | 2025 | 40014385 | PubTator, text mining | PubMed |
| Tumor immune microenvironment alterations associated with progression in human intraductal papillary mucinous neoplasms. | J Pathol | 2025 | 40001347 | PubTator, text mining | PubMed |
| Blebbisomes are large, organelle-rich extracellular vesicles with cell-like properties. | Nat Cell Biol | 2025 | 39984653 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64115/papers?page=9